Waters Corporation
$ 333.26
0.32%
19 May - close price
- Market Cap 32,721,420,000 USD
- Current Price $ 333.26
- High / Low $ 338.93 / 329.15
- Stock P/E 42.40
- Book Value 43.01
- EPS 7.86
- Next Earning Report 2026-07-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.05 %
- 52 Week High 414.15
- 52 Week Low 275.05
About
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
Analyst Target Price
$400.52
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-09 | 2025-11-04 | 2025-08-04 | 2025-05-06 | 2025-02-12 | 2024-11-01 | 2024-07-31 | 2024-05-07 | 2024-02-06 | 2023-11-07 | 2023-08-02 |
| Reported EPS | 2.7 | 4.53 | 2.5 | 2.95 | 2.25 | 4.1 | 2.93 | 2.63 | 2.21 | 3.62 | 2.84 | 2.8 |
| Estimated EPS | 2.31 | 4.51 | 2.99 | 2.94 | 2.22 | 4.03 | 2.68 | 2.56 | 2.09 | 3.55 | 2.55 | 2.59 |
| Surprise | 0.39 | 0.02 | -0.49 | 0.01 | 0.03 | 0.07 | 0.25 | 0.07 | 0.12 | 0.07 | 0.29 | 0.21 |
| Surprise Percentage | 16.8831% | 0.4435% | -16.388% | 0.3401% | 1.3514% | 1.737% | 9.3284% | 2.7344% | 5.7416% | 1.9718% | 11.3725% | 8.1081% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 3.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: WAT
2026-05-20 10:59:51
Labcorp has launched MyLabcorp, an AI-powered mobile app designed to help consumers understand their lab results and track health trends over time. The HIPAA-compliant app integrates Labcorp test results with OpenAI-powered explanations and clinically reviewed educational content. This initiative aims to address the growing consumer demand for clearer health information by providing personalized insights and facilitating more informed conversations with healthcare providers.
2026-05-20 05:47:02
Waters Corporation is gaining investor attention due to its upcoming presentation at the Jefferies Global Healthcare Conference and recent earnings impacted by one-off items. The company, a specialist in life sciences tools and analytical instruments, will be scrutinized for its core business model, key revenue drivers like chromatography and mass spectrometry, and its competitive position in a market driven by increasing regulatory standards and scientific complexity. Investors will be watching how the company normalizes margins and earnings after these unusual items subside, and how it manages competition and market fluctuations.
2026-05-19 03:18:42
Waters Corporation has launched a new multi-angle light scattering detector and is set to appear at the Jefferies Global Healthcare Conference, drawing fresh investor attention. The company's core business involves providing analytical instruments and software for chemical component analysis, with a focus on biopharmaceutical characterization. Waters' strategic moves, including product innovation and investor engagement, aim to strengthen its competitive position and address the evolving needs of the life sciences sector.
2026-05-18 23:38:48
SWISS RE LTD holds 36 shares of Waters Corp (WAT) valued at $10,720 as of March 31, 2026, representing 0.07% of its portfolio. The initial trade was in Q4 2025, and two purchases were made at an average price of $362.07. Currently, SWISS RE LTD has an estimated loss of $1,037.25 on its WAT holdings due to a -7.96% decline from the average purchase price.
2026-05-18 20:00:43
Waters Corporation (NYSE: WAT) announced that its President and CEO, Udit Batra, Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM ET. A live webcast and 90-day replay of the event will be available on Waters' investor relations website. This appearance is part of Waters' ongoing investor outreach, following strong Q1 2026 results and other positive company developments.
2026-05-18 00:37:26
Waters Corporation, a US-based specialist in analytical instruments and chromatography systems, is in focus after releasing its latest quarterly figures and updating its outlook for 2026. The article details the company's core business model, key revenue drivers, and competitive position within the life science tools industry. It also explains why Waters Corporation is relevant for US investors seeking exposure to the pharmaceutical and biotechnology sectors.
